Telocytes pp 139-147 | Cite as

The Potential Role of Telocytes for Tissue Engineering and Regenerative Medicine

  • Raymund E. Horch
  • Annika Weigand
  • Justus P. Beier
  • Andreas Arkudas
  • Anja M. Boos
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 913)

Abstract

Despite recent advances in surgery, medicine and anaesthesiology as well as the development of microsurgical tissue transplantation, wear out of body parts remains a problem, and organ shortage does not allow to allocate enough donor organs for patients with vital diseases and conditions. The idea to create spare parts or spare organs from the patients own cells by combining engineering approaches to cellular and molecular medicine for th purpose of Tissue Engineering (TE) was fascinating when popularized in the early 1990ies. However clinically success was limited, mainly because of a lack in rapid vascularization of large scale TE replacement constructs useful for clinical purposes. The idea to utilize cells and cytokines to aid the human organism in gradually restoring lost tissue functions has drawn attention to the wider field of Regenerative Medicine (RM). Stem cells and putative stem cells, such as the recently discovered and meanwhile well described interstitial Telocytes, which are comprised of extremely long and thin prolongations named telopodes, may well become active players in the regenerative process. This article highlights the principles of TE and RM and the potential role of Telocytes with regard to tissue regeneration.

References

  1. 1.
    Rana RE, Arora BS. History of plastic surgery in India. J Postgrad Med. 2002;48:76–8.PubMedGoogle Scholar
  2. 2.
    Jenkins DD, Yang GP, Lorenz HP, Longaker MT, Sylvester KG. Tissue engineering and regenerative medicine. Clin Plast Surg. 2003;30:581–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Popescu LM, Faussone-Pellegrini MS. TELOCYTES – a case of serendipity: the winding way from Interstitial Cells of Cajal (ICC), via Interstitial Cajal-Like Cells (ICLC) to TELOCYTES. J Cell Mol Med. 2010;14:729–40.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Popescu LM, Curici A, Wang E, Zhang H, Hu S, Gherghiceanu M. Telocytes and putative stem cells in ageing human heart. J Cell Mol Med. 2015;19:31–45.CrossRefPubMedGoogle Scholar
  5. 5.
    Popescu LM, Gherghiceanu M, Cretoiu D, Radu E. The connective connection: interstitial cells of Cajal (ICC) and ICC-like cells establish synapses with immunoreactive cells. Electron microscope study in situ. J Cell Mol Med. 2005;9:714–30.CrossRefPubMedGoogle Scholar
  6. 6.
    Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009;19:43–51.CrossRefPubMedGoogle Scholar
  7. 7.
    Zhao B, Chen S, Liu J, Yuan Z, Qi X, Qin J, Zheng X, Shen X, Yu Y, Qnin TJ, Chan JY, Cai D. Cardiac telocytes were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat. J Cell Mol Med. 2013;17:123–33.CrossRefPubMedGoogle Scholar
  8. 8.
    Zheng Y, Cretoiu D, Yan G, Cretoiu SM, Popescu LM, Fang H, Wang X. Protein profiling of human lung telocytes and microvascular endothelial cells using iTRAQ quantitative proteomics. J Cell Mol Med. 2014;18:1035–59.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Manetti M, Guiducci S, Ruffo M, Rosa I, Faussone-Pellegrini MS, Matucci-Cerinic M, Ibba-Manneschi L. Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis. J Cell Mol Med. 2013;17:482–96.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Manetti M, Rosa I, Messerini L, Guiducci S, Matucci-Cerinic M, Ibba-Manneschi L. A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis. J Cell Mol Med. 2014;18:253–62.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Wang F, Song Y, Bei Y, Zhao Y, Xiao J, Yang C. Telocytes in liver regeneration: possible roles. J Cell Mol Med. 2014;18:1720–6.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Franks I. Gallbladder: loss of interstitial Cajal-like cells in the gallbladder might contribute to gallstone formation. Nat Rev Gastroenterol Hepatol. 2012;9:689.CrossRefPubMedGoogle Scholar
  13. 13.
    Pasternak A, Gil K, Matyja A, Gajda M, Sztefko K, Walocha JA, Kulig J, Thor P. Loss of gallbladder interstitial Cajal-like cells in patients with cholelithiasis. Neurogastroenterol Motil: Off J Eur Gastrointest Motil Soc. 2013;25:e17–24.CrossRefGoogle Scholar
  14. 14.
    Qi G, Lin M, Xu M, Manole CG, Wang X, Zhu T. Telocytes in the human kidney cortex. J Cell Mol Med. 2012;16:3116–22.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Zheng Y, Zhu T, Lin M, Wu D, Wang X. Telocytes in the urinary system. J Transl Med. 2012;10:188.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Gevaert T, De Vos R, Van Der Aa F, Joniau S, van den Oord J, Roskams T, De Ridder D. Identification of telocytes in the upper lamina propria of the human urinary tract. J Cell Mol Med. 2012;16:2085–93.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Vannucchi MG, Traini C, Guasti D, Del Popolo G, Faussone-Pellegrini MS. Telocytes subtypes in human urinary bladder. J Cell Mol Med. 2014;18:2000–8.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Popescu LM, Gherghiceanu M, Suciu LC, Manole CG, Hinescu ME. Telocytes and putative stem cells in the lungs: electron microscopy, electron tomography and laser scanning microscopy. Cell Tissue Res. 2011;345:391–403.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Horch RE, Kneser U, Polykandriotis E, Schmidt VJ, Sun J, Arkudas A. Tissue engineering and regenerative medicine - where do we stand? J Cell Mol Med. 2012;16:1157–65.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Ceafalan LC, Popescu BO, Hinescu ME. Cellular players in skeletal muscle regeneration. BioMed Res Int. 2014;2014:957014.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Haines DD, Juhasz B, Tosaki A. Management of multicellular senescence and oxidative stress. J Cell Mol Med. 2013;17:936–57.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Bani D, Nistri S. New insights into the morphogenic role of stromal cells and their relevance for regenerative medicine. Lessons from the heart. J Cell Mol Med. 2014;18:363–70.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Bani D, Formigli L, Gherghiceanu M, Faussone-Pellegrini MS. Telocytes as supporting cells for myocardial tissue organization in developing and adult heart. J Cell Mol Med. 2010;14:2531–8.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Gherghiceanu M, Popescu LM. Cardiac telocytes – their junctions and functional implications. Cell Tissue Res. 2012;348:265–79.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Suciu L, Popescu LM, Gherghiceanu M, Regalia T, Nicolescu MI, Hinescu ME, Faussone-Pellegrini MS. Telocytes in human term placenta: morphology and phenotype. Cells Tissues Organs. 2010;192:325–39.CrossRefPubMedGoogle Scholar
  26. 26.
    Bojin FM, Gavriliuc OI, Cristea MI, Tanasie G, Tatu CS, Panaitescu C, Paunescu V. Telocytes within human skeletal muscle stem cell niche. J Cell Mol Med. 2011;15:2269–72.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Galiger C, Kostin S, Golec A, Ahlbrecht K, Becker S, Gherghiceanu M, Popescu LM, Morty RE, Seeger W, Voswinckel R. Phenotypical and ultrastructural features of Oct4-positive cells in the adult mouse lung. J Cell Mol Med. 2014;18:1321–33.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Popescu LM, Manole E, Serboiu CS, Manole CG, Suciu LC, Gherghiceanu M, Popescu BO. Identification of telocytes in skeletal muscle interstitium: implication for muscle regeneration. J Cell Mol Med. 2011;15:1379–92.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Suciu LC, Popescu BO, Kostin S, Popescu LM. Platelet-derived growth factor receptor-beta-positive telocytes in skeletal muscle interstitium. J Cell Mol Med. 2012;16:701–7.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Zheng Y, Zhang M, Qian M, Wang L, Cismasiu VB, Bai C, Popescu LM, Wang X. Genetic comparison of mouse lung telocytes with mesenchymal stem cells and fibroblasts. J Cell Mol Med. 2013;17:567–77.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Cretoiu SM, Popescu LM. Telocytes revisited. Biomol Concepts. 2014;5:353–69.CrossRefPubMedGoogle Scholar
  32. 32.
    Zhao B, Liao Z, Chen S, Yuan Z, Yilin C, Lee KK, Qi X, Shen X, Zheng X, Quinn T, Cai D. Intramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post-infarcted cardiac function in rats. J Cell Mol Med. 2014;18:780–9.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Polykandriotis E, Popescu LM, Horch RE. Regenerative medicine: then and now – an update of recent history into future possibilities. J Cell Mol Med. 2010;14:2350–8.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media Singapore 2016

Authors and Affiliations

  • Raymund E. Horch
    • 1
  • Annika Weigand
    • 1
  • Justus P. Beier
    • 1
  • Andreas Arkudas
    • 1
  • Anja M. Boos
    • 1
  1. 1.Department of Plastic and Hand Surgery and Laboratory of Tissue Engineering and Regenerative MedicineUniversity Hospital Erlangen, Friedrich Alexander University Erlangen-Nuernberg FAUErlangenGermany

Personalised recommendations